{"id":"NCT00948675","sponsor":"Eli Lilly and Company","briefTitle":"Study of Participants With Advanced Non-Small Cell Lung Cancer","officialTitle":"A Study of Pemetrexed Plus Carboplatin Followed by Maintenance Pemetrexed vs Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced NCSLC of Nonsquamous Histology","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09-01","primaryCompletion":"2013-01-31","completion":"2020-11-06","firstPosted":"2009-07-29","resultsPosted":"2014-04-02","lastUpdate":"2021-10-29"},"enrollment":361,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Pemetrexed","otherNames":["ALIMTA, LY231514"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"BIOLOGICAL","name":"Bevacizumab","otherNames":[]}],"arms":[{"label":"Pemetrexed + Carboplatin + Pemetrexed","type":"EXPERIMENTAL"},{"label":"Paclitaxel + Carboplatin + Bevacizumab","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the regimens of pemetrexed, carboplatin with pemetrexed maintenance and paclitaxel, carboplatin, bevacizumab with bevacizumab maintenance in participants with Stage IV nonsquamous non-small cell lung cancer.","primaryOutcome":{"measure":"Progression Free Survival Without Grade 4 Toxicity (G4PFS) as Measured by the Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0","timeFrame":"Randomization to measured progressive disease or treatment discontinuation up to 39.49 months","effectByArm":[{"arm":"Pemetrexed + Carboplatin","deltaMin":3.91,"sd":null},{"arm":"Paclitaxel + Carboplatin + Bevacizumab","deltaMin":2.86,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.176"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":21},"locations":{"siteCount":45,"countries":["United States"]},"refs":{"pmids":["25371077"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":76,"n":171},"commonTop":["Fatigue","Nausea","Anaemia","Constipation","Neutropenia"]}}